Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A * 0201-restricted E7-encoded epitope

Cancer Research

Volumn 56, Issue 3, 1996, Pages 582-588

  Ressing, Maaike E ^a   Van Driel, Willemien J ^a   Cells, Esteban ^b   Sette, Alessandro ^b   Brandt, Remco M P ^a   Hartman, Marrigje ^a   Anholts, Jacqueline D H ^a   Schreuder, Geziena M T ^a   Ter Harmsel, W Bram ^c   Fleuren, Gert Jan ^a   Trimbos, Baptist J ^a   Kast, W Martin ^a   Melief, Cornelis J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CYTEL CORPORATION   (United States)

^c REINIER DE GRAAF HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; VIRUS ANTIGEN;

ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; HLA TYPING; HUMAN; HUMAN CELL; INFLUENZA VIRUS; MEMORY CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; UTERINE CERVIX CANCER; VIRUS CHARACTERIZATION; VIRUS DETECTION; WART VIRUS;

AMINO ACID SEQUENCE; CERVICAL INTRAEPITHELIAL NEOPLASIA; EPITOPES; FEMALE; HLA-A ANTIGENS; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; T-LYMPHOCYTES, CYTOTOXIC; UTERINE CERVICAL NEOPLASMS;

EID: 0030020476     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Parkin, D. M., Pisani, P., and Ferlay, J. Estimates of the worldwide incidence of eighteen major cancers in 1985 Int. J. Cancer, 54: 594-606, 1993.
2. Zur Hausen, H. Human papillomavirus in the pathogenesis of anogenital cancer Virology, 184: 9-13, 1991.
3. Resnick, R. M., Cornelissen, M. T. E , Wright, D. K., Eichinger, G H., Fox, H. S., Ter Schegget, J , and Manos, M. M. Detection and Typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J. Natl Cancer Inst., 82, 1477-1484, 1990
4. Seedorf, K., Oltersdorf, T., Krämmer, G., and Röwekamp, W. Identification of early proteins of the human papillomaviruses type 16 (HPV16) and type 18 (HPV18) in cervical carcinoma cells. EMBO J , 6, 139-144, 1987.
5. Von Knebel Doeberirz, M , Bauknecht, T., Bartsch, D., and Zur Hausen, H. Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc. Natl. Acad Sci. USA, 88: 1411-1415, 1991.
6. Melief, C. J. M. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res., 58: 143-175, 1992.
7. Greenberg, P. D Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv. Immunol., 49, 281-355, 1991.
8. Townsend, A., and Bodmer, H. Antigen recognition by class I-restricted T lymphocytes Annu. Rev. Immunol. 7 601-624, 1989.
9. Rötschke, O., and Falk, K. Naturally occurring peptide antigens derived from the MHC class I-restricted processing pathway. Immunol. Today, 12: 447-455, 1991.
10. Bjorkman, P. J., and Parham, P. Structure, function, and diversity of class I major histocompatibility complex molecules Annu. Rev. Biochem., 59: 253-288, 1990.
11. Benton, C., Shahidullah, H., and Hunter, J. A. A. Human papillomavirus in the immunosuppressed. Papillomavirus Rep., 3: 23-26, 1992.
12. Honma, S , Tsukada, S , Honda, S , Nakamura, M., Takakuwa, K., Maruhashi, T., Kodama, S., Kanazawa, K., Takahashi, T., and Tanaka, K Biological-clinical significance of selective loss of HLA class I allelic product expression in squamous cell carcinoma of the uterine cervix. Int J. Cancer, 57 650-655, 1994.
13. Chen, L., Thomas, E. K., Hu, S. L., Hellstrom, I., and Hellstrom, K. E Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc. Natl. Acad. Sci. USA, 88: 110-114, 1991.
14. Feltkamp, M. C. W., Smits, H L., Vierboom, M. P M., Minnaar, R. P., De Jongh, B. M., Drijfhout, J. W., Ter Schegget, J., Melief, C. J. M., and Kast, W. M. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human Papillomavirus type 16-transformed cells. Eur. J. Immunol., 23: 2242-2249, 1993.
15. Feltkamp, M C. W., Vreugdenhil, G. R., Vierboom, M. P M., Ras, E., Van der Burg, S. H., Ter Schegget, J , Melief, C. J. M., and Kast, W. M. CTL raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors. Eur J Immunol., 25: 2638-2642, 1995.
16. Meneguzzi, G., Cerni, C., Kieny, M. P., and Lathe, R. Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressins E6 and E7. Virology, 181: 62-69, 1991.
17. Kast, W. M., Brandt, R. M. P., Drijfhout, J. W., and Melief, C. J. M. Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papulomavirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2. J. Immunother., 14: 115-120, 1993.
18. Kast, W M., Brandt, R M P., Sidney, J., Drijfhout, J. W., Kubo, R. T , Grey, H. M., Melief, C J M., and Sette, A. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J. Immunol., 152, 3904-3912, 1994.
19. Ressing, M E., Sette, A., Brandt, R M. P , Ruppert, J., Wentworth, P. A., Hartman, M., Oseroff, C., Grey, H. M., Melief, C. J. M , and Kast, W. M. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunegenicity studies of HLA-A*0201-binding peptides. J. Immunol., 154: 5934-5943, 1995.
20. Bednarek, M. A., Sauma, S. Y., Gammon, M. C., Porter, G., Tamhankar, S. Williamson, A. R., and Zweerink, H. J. The minimum peptide epitope from the influenza virus matrix protein. Extra and intra-cellular loading of HLA-A2. J. Immunol., 147: 4047-4053, 1991.
21. Claas, E. C. J., Melchers, W. J. G., Van der Linden, H. C., Lindeman, J., and Quint, W. G. V. Human papillomavirus detection in paraffin-embedded cervical carcinomas and metastases of the carcinomas by the polymerase chain reaction. Am J. Pathol., 135: 703-709, 1989
22. Krausa, P., Brywka, M., III, Savage, D., Hui, K. M., Bunce, M , Ngai, J. L. F., Teo, D. L T., Ong, Y. W., Barouch, D , Allsop, C E. M., Hill, A. V. S., McMichael, A. J , Bodmer, J. G., and Browning, M J Genetic polymorphisms within HLA-A*02: significant allelic variation revealed in different populations. Tissue Antigens, 45 223-231, 1995.
23. Pattillo, R. A., Hussa, R. O., Story, M T , Ruckert, A. C. F , Shalaby, M R , and Mattingly, R. F. Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line Science (Washington DC), 196: 1456-1458, 1977.
24. Vitiello, A., Ishioka, G , Grey, H. M., Rose, R., Farness, P., LaFond, R., Yuan, L., Chisari, F. V., Furze, J., Bartholomeuz, R., and Chesnut, R W. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection I Induction of a primary cytotoxic T lymphocyte response in humans. J. Clin. Invest., 95: 341-349, 1995
25. Sette, A , Sidney, J , Del Guercio, M F., Southwood, S., Ruppert, J., Grey, H. M., and Kubo, R T Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol. Immunol., 31: 813-822, 1994.
26. Mizoguchi, H., O'Shea, J. J., Longo, D. L., Loeffler, C. M., McVicar, D W., and Ochoa, A. C. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science (Washington DC), 258: 1795-1798, 1992.
27. Connor, M E., and Stern, P L. Loss of MHC class I expression in cervical carcinomas Int. J. Cancer, 46: 1029-1034, 1990
28. Cromme, F. V., Airey, J., Heemels, M. T., Ploegh, H. L. Keating, P. J., Stern, P. L , Meijer, C. J. L M., and Walboomers, J. M. M. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas J. Exp. Med., 179: 335-340, 1994.
29. Alexander, J , Sidney, J., Southwood, S , Ruppert, J., Oseroff, C., Maewal, A., Snoke, K., Serra, H. M., Kubo, R. T., Sette, A., and Grey, H. M. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides Immunity, 1: 751-761, 1994